Page 4 - Shikma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Shikma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Shikma Today - Breaking & Trending Today

Hikma appoints Riad Mishlawi as CEO

Hikma Pharmaceuticals said Riad Mishlawi, president of the group's injectables business, has been appointed chief executive Officer, effective from September 1. ....

Hikma Pharmaceuticals , Riad Mishlawi , Category All , Category Company News , Category News And Announcements , Category Sectorial Health Technology ,

Hikma Pharma FY22 Results Down, Lifts Dividend; Says Confident Of FY23 Growth; Stock Up

LONDON (dpa-AFX) - Shares of Hikma Pharmaceuticals PLC (HIK, HIK.L) were gaining around 4 percent in the early morning trading in London after the company on Thursday said it is confident of fiscal ....

City Of , United Kingdom , Dennis Riedl , Hikma Pharma , Hikma Pharmaceuticals , Executive Chairman , Chief Executive Officer ,

Junshi Bioscience and Hikma expand cancer treatment to Middle East and North Africa

Hikma and Junshi Biosciences sign exclusive licensing agreement for cancer treatment drug toripalimab for the Middle East and North Africa region
....

United States , Junshi Bioscience , Southeast Asia , Junshi Biosciences , Middle East ,

Hikma Pharma Says Outlook For All Divisions Intact

LONDON (dpa-AFX) - Hikma Pharmaceuticals PLC (HIK) Thursday said its full-year outlook for all of its three segments including Injectables, Branded, and Generics remain unchanged. 'We are seeing ....

City Of , United Kingdom , Hikma Pharmaceuticals , Said Darwazah , Executive Chairman , Chief Executive Officer ,

Hikma Pharmaceuticals Reports Lower H1 Profit; Sets Interim Dividend

LONDON (dpa-AFX) - Hikma Pharmaceuticals PLC (HIK) on Thursday reported profit before tax of $215 million for the first half, lower than $319 million in the year-ago period.Excluding one-time items ....

City Of , United Kingdom , Hikma Pharmaceuticals ,